OKUR — Onkure Therapeutics Share News
0.000.00%
Last trade - 00:00- $102.05m
- -$74.34m
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker
Onkure Therapeutics Inc expected to post a loss of $1.08 a share - Earnings Preview
Brief: Cormorant Asset Management, Lp Reports 14.98% Passive Stake In Onkure Therapeutics Inc As Of Oct 4- SEC Filiing
Brief: Acorn Bioventures, L.P. Reports 11.4% Passive Stake In Onkure Therapeutics Inc As Of Oct 4
Brief: Onkure Announces Closing Of Merger With Reneo Pharmaceuticals And Concurrent Private Placement Of $65 Million
Brief: Reneo Pharmaceuticals Announces Stockholder Approval Of Merger With Onkure
Reneo Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Reneo Pharmaceuticals Q2 EPS USD -0.16
Reneo Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Reneo Pharmaceuticals and OnKure Announce Proposed Merger
Reneo Pharmaceuticals Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Reneo Pharmaceuticals Q1 EPS USD -0.25
Reneo Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Reneo Pharmaceuticals Q4 EPS USD -0.7
Brief: Sagimet Biosciences Announces Appointment Of Tim Walbert And Paul Hoelscher To Board Of Directors
Reneo Pharmaceuticals Inc expected to post a loss of 58 cents a share - Earnings Preview